• No results found

PK-A

Observation of Λb0 → ψ(2S)pK− and Λb0 → J/ψπ+π−pK− decays and a measurement of the Λb0 baryon mass

Observation of Λb0 → ψ(2S)pK− and Λb0 → J/ψπ+π−pK− decays and a measurement of the Λb0 baryon mass

... The mass distributions for selected Λ 0 b → ψ(2S)[→ µ + µ − ]pK − candidates and candidates for the normalization channel Λ 0 b → J /ψ pK − are shown in figure 1. Signal yields are deter- mined using ...

22

Religion and/or A business? A critical reading of Tree without Roots and PK

Religion and/or A business? A critical reading of Tree without Roots and PK

... and PK- a film by Rajk umar Hirani, the paper argues that ‘pseudo-religious operation’ creates inconsistency among religious ideologies and deviates people from religious ideology to religious superstition, and ...

7

Biphasic Functional Interaction between the Adenovirus E4orf4 Protein and DNA-PK

Biphasic Functional Interaction between the Adenovirus E4orf4 Protein and DNA-PK

... ABSTRACT The adenovirus (Ad) E4orf4 protein contributes to virus-induced inhibi- tion of the DNA damage response (DDR) by reducing ATM and ATR signaling. Con- sequently, E4orf4 inhibits DNA repair and sensitizes ...

21

Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter

Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter

... by PK and decreased endogenous LMP1 protein levels in lyticly induced type III latency cells suggest that the LMP1 promoter may be down-regulated dur- ing the lytic ...by PK might contribute to the ...

6

Drugability Studies are Keys to the Successful Commercialization of Biotherapeutics

Drugability Studies are Keys to the Successful Commercialization of Biotherapeutics

... 3). PK data of biologics such as C max , Area Under Curve (AUC), half-life, volume of distribution, and clearance can help provide significant insight into their stability in blood, potential nonlinearity of ...

9

Pharmacokinetics of Chinese medicines: strategies and perspectives

Pharmacokinetics of Chinese medicines: strategies and perspectives

... classic PK strategies have evolved rapidly from PK study focusing on marker/main drug components to PK-PD correlation study adopting metabolomics approaches to characterize associations between ...

12

A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors

A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors

... Purpose: Ridaforolimus (AP23573, MK-8669 or deforolimus) is an inhibitor of mammalian target of rapamycin (mTOR), an important regulator in the cell survival pathway. This open-label, single center phase I study aimed to ...

6

Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous hemodiafiltration on different anticoagulant modalities

Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous hemodiafiltration on different anticoagulant modalities

... population PK facilitates the use of sparse data and also dense data, or even a combination of dense/sparse data to gain integrated information on ...population PK a great advantage for analysing the data ...

149

Chemical Reactivity Theory (CRT) Study of the Melanoidin M8: Local Conceptual Density Functional Theory Descriptors

Chemical Reactivity Theory (CRT) Study of the Melanoidin M8: Local Conceptual Density Functional Theory Descriptors

... Finally, the condensed electrophilic and nucleophilic Parr functions Pk+ and Pk− over the atoms of the Melanoidin M8 molecule in water have been calculated by extracting the Mulliken or [r] ...

11

Prevalence of Pyruvate Kinase Deficiency among the Newborns (Shiraz-Iran)

Prevalence of Pyruvate Kinase Deficiency among the Newborns (Shiraz-Iran)

... Except for G6PD and Phosphoglycerate kinase which are X-linked, the other 12 hereditary erythrocyte enzyme abnormalities that result in heridatery non-spherocytic hemolytic anemia (HNSHA) have autosomal recessive (AR) ...

5

Obstacle to peace? Ethnic geography and effectiveness of peacekeeping

Obstacle to peace? Ethnic geography and effectiveness of peacekeeping

... Model A3 Total PK Armed Personnel Variables UN PK Troops&Police Ethnic Polarization Ethnic Polarization # UN PK Civilian Deaths Population log Purchase Power Parity log Capital Distance [r] ...

59

Attribute Based Encryption for Data Sharing in Cloud

Attribute Based Encryption for Data Sharing in Cloud

... Encryption: The sender(Us) uses the encryption algorithm Encr(PK,M,Ss) which takes public parameters(PK),Message(M), the attribute set of the sender Ss as input andoutputs the Ciphertext(CT). In other words ...

5

DNA-PK Deficiency in Alzheimer's Disease

DNA-PK Deficiency in Alzheimer's Disease

... 65. Liu S, Opiyo SO, Manthey K, et al. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress. Nucleic Acids Res. 2012;40(21):10780-94. 66. ...

6

The design and investigation of model based internal model control for the regulation of hypnosis

The design and investigation of model based internal model control for the regulation of hypnosis

... blocks PK and PD together with the nonlinear equation represent the patient’s pharmacokinetics and pharmacodynamics, ...Both PK and PD are single-input single-output linear time invariant ...

6

Pharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study

Pharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study

... 28 % higher than East Asian RRMM patients on day 1 of dosing (194 [78 % CV] vs 152 [95 % CV] ng*h/ mL/mg, respectively) and 49 % higher on day 15 (401 [48 % CV] vs 269 [44 % CV] ng*h/mL/mg, respect- ively). However, ...

9

A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology

A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology

... a PK model is developed to describe the rela- tionship between dose and PK metrics, such as trough concen- tration, area under concentration (AUC), and time course of concentration ...between PK and ...

8

Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study

Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study

... Noncompartmental pharmacokinetic analysis of fimasartan was performed using WinNonlin (Version 6.3.0; Pharsight Corporation, CA, USA). The actual times at which the blood samples were obtained were used in the PK ...

9

Diego interacts with Prickle and Strabismus/Van Gogh to localize planar cell polarity complexes

Diego interacts with Prickle and Strabismus/Van Gogh to localize planar cell polarity complexes

... To provide biochemical evidence for a PCP multiprotein complex, we tested for physical interactions between these factors in a yeast two-hybrid matrix with available PCP proteins (A.J. and M.M., unpublished). This ...

10

A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis.

A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis.

... PK models were identified through a systematic review of the literature, with a focus on population PK (popPK) models. This process included a search of major databases “Medline” and “EMBASE + Embase ...

11

Role of tacrolimus prolonged release in the prevention of allograft rejection

Role of tacrolimus prolonged release in the prevention of allograft rejection

... A second PK study of PR in transplant patients involved an open-label multicenter PK study in liver transplant recipients with stable graft function on standard tacrolimus the[r] ...

6

Show all 10000 documents...

Related subjects